GetFit Weight Loss and Zepbound

Throughout a 17-month clinical trial, people who dieted, exercised, and took Zepbound sustained weight loss—whether taking the 5-mg, 10-mg, or 15-mg dose.

In a 72-week study, patients who took Zepbound reduced their caloric intake and increased their physical activity loss, with an average weight loss of 15.0% (34 lbs) for 5 mg, 19.5% (44 lbs) for 10 mg, 20.9% (48 lbs) for 15 mg, and 3.1% (7 lbs) for placebo.

In a 72-week study of adults with diabetes, average weight loss was 12.8% (28 lbs) for 10 mg, 14.7% (33 lbs) for 15 mg, and 3.2% (7 lbs) for placebo.